R-CHOP regimen

OTHER3 trials

Sponsors

French Innovative Leukemia Organisation, SWOG Cancer Research Network, Sun Yat-sen University

Conditions

Diffuse Large B-Cell LymphomaLymphoma

Phase 1

Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL

RecruitingNCT06760039

Sun Yat-sen UniversityDiffuse Large B-Cell Lymphoma

Start: 2025-01-10End: 2028-11-30Target: 112Updated: 2025-04-03

Phase 2

GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma

French Innovative Leukemia OrganisationLymphoma

Start: 2009-03-31Target: 30Updated: 2013-08-02

S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma

CompletedNCT01359592

SWOG Cancer Research NetworkLymphoma

Start: 2011-09-30End: 2023-12-31Updated: 2025-06-17

Related Papers

Development of a Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma

Blood2022-11-15